BDBM635229 US11814367, Compound 678::US11814367, Compound 680

SMILES Cc1cc(C(NC(=O)[C@@H]2C[C@@H](F)CN2C(=O)Cc2cnn[nH]2)c2ccccc2)cc(F)c1C(C)C

InChI Key InChIKey=BOTJHSVVKQSPAH-UHFFFAOYSA-N

Data  3 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 635229   

TargetGlycogen [starch] synthase, muscle(Human)
Maze Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 635229BDBM635229(US11814367, Compound 678 | US11814367, Compound 68...)
Affinity DataIC50: 15nMAssay Description:Compounds that inhibit the hGYS1 enzyme and, subsequently, the downstream conversion of NADH to NAD+, were tested using assay ready plates (black, cl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/8/2024
Entry Details
US Patent

TargetGlycogen [starch] synthase, muscle(Human)
Maze Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 635229BDBM635229(US11814367, Compound 678 | US11814367, Compound 68...)
Affinity DataIC50: 1.07E+3nMAssay Description:Compounds that inhibit the hGYS1 enzyme and, subsequently, the downstream conversion of NADH to NAD+, were tested using assay ready plates (black, cl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/8/2024
Entry Details
US Patent

TargetGlycogen [starch] synthase, liver(Human)
Maze Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 635229BDBM635229(US11814367, Compound 678 | US11814367, Compound 68...)
Affinity DataIC50: 9.30E+4nMAssay Description:Compounds that inhibit the hGYS2 enzyme and, subsequently, the downstream conversion of NADH to NAD+, were tested using assay ready plates (black, cl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/8/2024
Entry Details
US Patent